Description

4-(Acetyloxy)-1-Ethyl-3-(2-(1-Methyl-5-Nitro-1H-Imidazol-2-Yl)Ethenyl) -2(1H)-Quinolinone is a specialized heterocyclic organic compound that serves as a critical advanced pharmaceutical intermediate and a versatile building block in synthetic chemistry. Its complex molecular architecture, featuring fused quinolinone and nitroimidazole moieties, makes it valuable for the research and development of novel bioactive molecules. This compound is primarily sought by pharmaceutical R&D and fine chemical synthesis sectors for creating potential therapeutic agents.

Application

• Pharmaceutical Intermediate: Key precursor in the synthesis of novel drug candidates, particularly those targeting infectious diseases or cancer.
• Antimicrobial Research: Serves as a core scaffold for developing new compounds with potential antibacterial or antiprotozoal activity, leveraging the nitroimidazole pharmacophore.
• Chemical Biology Probes: Used in academic and industrial research to study enzyme interactions and biological pathways.
• Organic Synthesis Building Block: Employed in complex multi-step syntheses to introduce the unique 1-ethyl-2-quinolinone structure into target molecules.
• Material Science Research: Investigated for potential applications in creating specialized organic materials due to its conjugated system.

Basic Information

Item	Detail
Product Name	4-(Acetyloxy)-1-Ethyl-3-(2-(1-Methyl-5-Nitro-1H-Imidazol-2-Yl)Ethenyl) -2(1H)-Quinolinone
CAS No.	74693-60-0
Molecular Formula	C19H18N4O5
Molecular Weight	382.37 g/mol
Synonyms	1-Ethyl-4-(acetyloxy)-3-[2-(1-methyl-5-nitro-1H-imidazol-2-yl)ethenyl]-2(1H)-quinolinone; 4-Acetoxy-1-ethyl-3-[2-(1-methyl-5-nitroimidazol-2-yl)vinyl]quinolin-2-one; EN 313; 1-Ethyl-4-acetoxy-3-[2-(1-methyl-5-nitroimidazol-2-yl)vinyl]-2-quinolone; 4-Acetyloxy-1-ethyl-3-(2-(1-methyl-5-nitro-1H-imidazol-2-yl)ethenyl)-2(1H)-quinolinone; 4-(Acetyloxy)-1-ethyl-3-[2-(1-methyl-5-nitro-1H-imidazol-2-yl)ethenyl]-2(1H)-quinolinone
EINECS	Contact for details

Quality Control

Our 4-(Acetyloxy)-1-Ethyl-3-(2-(1-Methyl-5-Nitro-1H-Imidazol-2-Yl)Ethenyl) -2(1H)-Quinolinone is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and NMR/IR for structural confirmation, to ensure it meets the high standards required for pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep the container tightly sealed to protect from moisture and contamination. Store away from incompatible materials.

Specification

Item	Specification
Appearance	Yellow to light brown crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.